To view a copy of this licence, visit About this article Cite this article Nadeem, R., Barakat, A.B
Type 2 Diabetes Prevention Focused on Normalization of Glycemia: A Two-Year Pilot Study
Davies M, Frch L, Jeppesen OK, Pakseresht A, Pedersen SD, Perreault L, Rosenstock J, Shimomura I, Viljoen A, Wadden TA
Store refrigerated between 2C and 8C and protect the product from heat, moisture, and direct sunlight
Moreover, as a GLP-1 receptor agonist, semaglutide carries potential side effects and uncertainty regarding its long-term impact when used primarily for weight loss
There are currently around 1.5 million people in the UK using GLP-1 drugs, of whom the vast majority 95% are thought to access the medication privately, where they are not always provided with the additional nutritional advice and support